<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02496806</url>
  </required_header>
  <id_info>
    <org_study_id>SWAFAX11/18</org_study_id>
    <nct_id>NCT02496806</nct_id>
  </id_info>
  <brief_title>The Absorption and Metabolism of Seaweed Polyphenols in Humans</brief_title>
  <acronym>SWAFAX</acronym>
  <official_title>Seaweed Derived Anti-inflammatory Agents and Antioxidants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ulster</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brown seaweeds are a rich source of phlorotannins, a characteristic class of polyphenols
      which are unique to seaweeds of this type and can comprise 5 to 15 % of the dried weight.
      Unlike other classes of polyphenols, there is a lack of knowledge regarding phlorotannins and
      their bioavailability and bioactivity. The purpose of this study is to investigate the
      absorption and metabolism of seaweed polyphenols in humans. As part of an EC project
      (SWAFAX), an acute clinical intervention will be conducted to investigate the metabolism/
      bioavailability of brown seaweed phlorotannins. Urine and plasma samples from 24 healthy
      volunteers that consumed a seaweed capsule containing polyphenols will be collected before
      and after the intervention. Data emanating from this project will provide strong scientific
      evidence for bioavailability and health promoting activity of a seaweed polyphenol extract in
      human volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Seaweed polyphenol metabolites in urine</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Seaweed polyphenol metabolites in plasma</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Citokine levels in plasma</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400mg capsule containing seaweed extract (treatment) Intervention: Dietary Supplement: Treatment capsule containing seaweed extract (treatment)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Seaweed extract</intervention_name>
    <description>Treatment capsule containing seaweed extract (treatment)</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good general health

          -  Body Mass Index of 18-30 Kg/m2

        Exclusion Criteria:

          -  Inability to swallow capsules

          -  Smoking

          -  Alcohol intake of &gt;21 units/wk

          -  Blood pressure &gt; 150/90 mmHg

          -  Any dietary restrictions or weight reducing diet

          -  Vegetarian

          -  Heamoglobin levels&lt; 125 g/l for male, &lt; 110 g/l for female,

          -  Gamma GT levels &gt; 80 IU/l

          -  Cholesterol levels &gt; 6.5 mmol/l

          -  Myocardial infarction or stroke in the previous 12 months

          -  Gastrointestinal disease or chronic gastrointestinal disorders

          -  Reproductive disorder

          -  Blood-clotting disorder

          -  Metabolic disorders

          -  Lipid-modifying medication

          -  Blood clotting mdication

          -  Antibiotic medication in previous 3 months before study

          -  Lactation

          -  Pregnancy

          -  Females of childbearing potential and not using effective contraceptive precautions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 24, 2015</study_first_submitted>
  <study_first_submitted_qc>July 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2015</study_first_posted>
  <last_update_submitted>July 9, 2015</last_update_submitted>
  <last_update_submitted_qc>July 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Reading</investigator_affiliation>
    <investigator_full_name>DR GIULIA CORONA</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Polyphenols</keyword>
  <keyword>Absorption</keyword>
  <keyword>Metabolism</keyword>
  <keyword>Phlorotannins</keyword>
  <keyword>Seaweeds</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

